www.mmm-online.com

www.mmm-online.com
Share

www.mmm-online.com

 •  October 18

Procter & Gamble was one of several big consumer-packaged goods firms to pare back marketing spend this past year, part of an effort to end ineffective advertising. Drugmakers have stepped up vigilance, too, with a few instituting cost-cutting.It's unlikely that these moves are a direct response to anything done by P&G, said Andrea Palmer, SVP,...

www.mmm-online.com

 •  September 28

After several years marked by lackluster debuts and a relatively low amount of innovation, the women's health sector is heating up again. But it's not just about new products hitting the market or old ones being repurposed. Rather, drug companies have adopted new strategies around mainstay therapeutics, broadening the definition of what should be...

www.mmm-online.com

 •  August 9

It may have taken longer than it did elsewhere, but pharma has finally achieved some not-insignificant degree of comfort and confidence in the realm of social media. Medical loss ratio-fueled worries notwithstanding, brand teams have marketed their products on Facebook, Instagram, and Twitter to great effect, achieving results that make deeper...

www.mmm-online.com

 •  August 1

It's no secret that American healthcare suffers from an empathy deficit. While brusque doctors have been blighting patient-satisfaction surveys for years, providers themselves increasingly say it's a problem: In a Harvard Medical School survey, 53% of doctors reported declining levels of patient empathy.Pharma is increasingly unhappy with the...

www.mmm-online.com

 •  July 26

Astellas Pharma promoted David Musselman to area VP of sales for primary care and specialty for the East Coast, and it also named Lynn Gerber to the same role for the West Coast. Musselman and Gerber each lead a team of five sales directors, who are part of Astellas' 370-member primary care and specialty teams. Musselman is based in Charleston,...

www.mmm-online.com

 •  July 24

Analysts recently applauded promising clinical trial results for two late-stage cardiovascular drugs but commercial success for the therapies, if approved, will likely be challenging, given the recent access challenges faced by novel heart drugs like Novartis' Entresto and Amgen's Repatha.Novartis said in June that its experimental canakinumab,...

www.mmm-online.com

 •  July 24

Internet Health Brands, a company owned by private equity firm KKR, said it plans to acquire WebMD in a deal worth roughly $2.8 billion.The news of the acquisition comes less than six months after WebMD CEO Steven Zatz told investors that the company was exploring strategic options, including an acquisition. WebMD's board has approved the deal,...

www.mmm-online.com

 •  June 16

Communications experts are calling on drugmakers to come together in a leadership role to take on the country's opioid crisis head on, going well beyond compliance with Food and Drug Administration warnings about the addiction risks posed by prescription painkillers. PRWeek contacted more than a dozen major drugmakers with opioid products. They...

www.mmm-online.com

 •  May 31

We probably should have seen this coming. When QuintilesIMS issued its annual report Medicines Use and Spending in the U.S. in April 2016, it disclosed that drug spends had grown by 12% in 2015 compared to 2014. But when factoring in rebates given to payers and other price concessions, that figure shrank to around 8.5%.So nobody was entirely sure...

www.mmm-online.com

 •  May 18

Only 34% of physicians find pharmaceutical content on HCP sites to be trustworthy, according to a new study by Decision Resources Group's Manhattan Research. “We found that pharma is missing the mark when it comes to providing online content that physicians need in an easy-to-use way,” said Kelly Pinola, senior analyst of physician research at...